Cardinal Health, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Jason Hollar
- Full Time Employees
- 61,344
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Address
- 7000 Cardinal Place Dublin OH United States of America 43017
- IPO Date
- Aug 4, 1983
- CIK
- 0000721371
- Website
- cardinalhealth.com
- Similar Companies
- Business
- Cardinal Health, Inc. (NYSE: CAH) provides integrated healthcare services and products, distributing pharmaceuticals and medical supplies to hospitals, pharmacies, and healthcare providers worldwide. The company manufactures branded and private-label medical, surgical, and laboratory products, including masks, gloves, gowns, and exam apparel under brands such as Aspen Surgical, Cardinal Health, and Trudell; offers nuclear pharmacy services, patient safety solutions, and pharmacy management software; and operates through three main segments: Pharmaceutical, Medical, and Home Health & Hospice. Its product portfolio encompasses over 20,000 national brand pharmaceuticals, over 2,000 generic drugs, and a broad range of medical-surgical supplies like needles, syringes, IV sets, and wound care items; services include third-party logistics, specialty pharmaceutical distribution, and proprietary navigation technology for at-home care. Cardinal Health serves independent retail pharmacies, chains, hospitals, ambulatory surgery centers, clinical laboratories, and physician offices primarily in the United States, Canada, and Puerto Rico, with headquarters in Dublin, Ohio, where it was founded in 1971. In recent developments, Cardinal Health completed the acquisition of Integrated Pharmacy Solutions in October 2024, expanding its 503A sterile compounding capabilities to support hospital pharmacies nationwide; launched a new Advanced Call Center in July 2024 to enhance customer service for its Medical segment; and announced a strategic distribution agreement with the Novo Nordisk Patient Assistance Program (PAP) in November 2024 to broaden access to essential medications. The company also secured a five-year Pharmaceutical Supply Agreement with the U.S. Department of Veterans Affairs in September 2024 valued at approximately $9.3 billion, reinforcing its position as a key government supplier; introduced the Cordless Navigation System for orthopedic procedures in 2024; and completed the divestiture of its Health Care Compliance business to RLDatix in December 2024. These moves reflect ongoing efforts to optimize operations, grow in high-margin areas like sterile compounding and navigation technology, and strengthen partnerships amid supply chain challenges.
Company News
CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?
Cardinal (CAH) Up 2.5% Since Last Earnings Report: Can It Continue?
Cardinal Health, Inc. (CAH) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Cardinal Health (CAH) Declines More Than Market: Some Information for Investors
Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?
Here's Why Cardinal Health (CAH) is a Strong Value Stock
Cardinal Health (CAH) is a Top-Ranked Growth Stock: Should You Buy?
Is Generics Still a Quiet Profit Engine for Cardinal Health?
Neurocrine's Crenessity Gains Ground in CAH: How Far Can Sales Go?
3,554 Shares in Cardinal Health, Inc. $CAH Bought by Connor Clark & Lunn Investment Management Ltd.
Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy?
Cardinal Health, Inc. $CAH Shares Bought by Algert Global LLC
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
What to Know About the Latest Sale From Cardinal Health's Chief Accounting Officer
Cardinal Health's CFO Moved $9.9 Million of Stock. Here's What Long-Term Investors Should Know
Cardinal Health's Medical Segment Boss Sold $8 Million in Stock. Here's What to Know
Cardinal Health's Pharma Chief Sold 7,354 Shares and Still Grew Her Stake by 47%. Here's How That Happened
The CIO of Cardinal Health Parted With 11,650 Shares. Here's Whether It Matters for Long-Term Investors
Cardinal Health's Legal Chief Just Filed an Insider Transaction. Here's What to Know
Cardinal Health's CEO Moved 124,529 Shares in Two Days. Here's What Long-Term Investors Should Know